Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 26;11(6):719. doi: 10.3390/antibiotics11060719

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Forest plot of odds ratios for the comparisons of mortality outcomes between patients with pneumocystis pneumonia who received TMP–SMX + echinocandin combination therapy and those who received TMP–SMX monotherapy. (A) Overall results for all patients with pneumocystis pneumonia; (B) HIV-infected patients with pneumocystis pneumonia; (C) Non-HIV-infected patients with pneumocystis pneumonia. echinocandin −, TMP–SMX monotherapy; echinocandin +, TMP–SMX + echinocandin combination therapy; M–H, Mantel–Haenszel; CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio; SMX, sulfamethoxazole; TMP, trimethoprim.